BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25012173)

  • 1. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
    Ma L; Shelness GS; Snipes JA; Murea M; Antinozzi PA; Cheng D; Saleem MA; Satchell SC; Banas B; Mathieson PW; Kretzler M; Hemal AK; Rudel LL; Petrovic S; Weckerle A; Pollak MR; Ross MD; Parks JS; Freedman BI
    J Am Soc Nephrol; 2015 Feb; 26(2):339-48. PubMed ID: 25012173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.
    Wakashin H; Heymann J; Roshanravan H; Daneshpajouhnejad P; Rosenberg A; Shin MK; Hoek M; Kopp JB
    BMC Nephrol; 2020 Aug; 21(1):371. PubMed ID: 32854642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
    Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
    Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
    Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
    Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
    Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.
    Fang J; Yao X; Hou M; Duan M; Xing L; Huang J; Wang Y; Zhu B; Chen Q; Wang H
    Biochem Biophys Res Commun; 2020 Jun; 527(2):466-473. PubMed ID: 32336543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.
    Sawai K; Mukoyama M; Mori K; Kasahara M; Koshikawa M; Yokoi H; Yoshioka T; Ogawa Y; Sugawara A; Nishiyama H; Yamada S; Kuwahara T; Saleem MA; Shiota K; Ogawa O; Miyazato M; Kangawa K; Nakao K
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1363-72. PubMed ID: 17699553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys.
    Blessing NA; Wu Z; Madhavan SM; Choy JW; Chen M; Shin MK; Hoek M; Sedor JR; O'Toole JF; Bruggeman LA
    PLoS One; 2021; 16(6):e0253197. PubMed ID: 34138902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.
    Lan X; Wen H; Saleem MA; Mikulak J; Malhotra A; Skorecki K; Singhal PC
    Exp Mol Pathol; 2015 Jun; 98(3):491-501. PubMed ID: 25796344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?
    Olabisi O; Al-Romaih K; Henderson J; Tomar R; Drummond I; MacRae C; Pollak M
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):114-118. PubMed ID: 27509583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
    Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
    PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes.
    Scales SJ; Gupta N; De Mazière AM; Posthuma G; Chiu CP; Pierce AA; Hötzel K; Tao J; Foreman O; Koukos G; Oltrabella F; Klumperman J; Lin W; Peterson AS
    J Am Soc Nephrol; 2020 Sep; 31(9):2044-2064. PubMed ID: 32764142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
    Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
    PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
    Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
    Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.
    Bondeva T; Roger T; Wolf G
    Am J Nephrol; 2007; 27(3):308-14. PubMed ID: 17495427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
    Sampson MG; Robertson CC; Martini S; Mariani LH; Lemley KV; Gillies CE; Otto EA; Kopp JB; Randolph A; Vega-Warner V; Eichinger F; Nair V; Gipson DS; Cattran DC; Johnstone DB; O'Toole JF; Bagnasco SM; Song PX; Barisoni L; Troost JP; Kretzler M; Sedor JR;
    J Am Soc Nephrol; 2016 Mar; 27(3):814-23. PubMed ID: 26150607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
    Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
    BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
    Anderson BR; Howell DN; Soldano K; Garrett ME; Katsanis N; Telen MJ; Davis EE; Ashley-Koch AE
    PLoS Genet; 2015 Jul; 11(7):e1005349. PubMed ID: 26147622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of
    Haque S; Patil G; Mishra A; Lan X; Popik W; Malhotra A; Skorecki K; Singhal PC
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28385815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.